Market Research Logo

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2018-2022)

Global Human Growth Hormone (hGH) Market: Industry Analysis & Outlook (2018-2022)

Human growth hormone is produced by the pituitary gland and it spurs growth in children and adults. It regulates body fluids, muscle and bone growth and fat metabolism of the body. Growth hormone is important for normal functioning in humans. The deficiency of growth hormone is termed as Growth Hormone Deficiency (GHD) and it can be tackled by administering intramuscular or subcutaneous GH injections on daily basis.

In the coming years, this disorder can be treated by various therapeutics which are currently in their final phase of development. This would change the complete market scenario because at present only daily agents are used to treat GHD. The global human growth hormone market is likely to see strong pipeline of drugs with increased research and development activities, which would spur innovation in the market.

The global human growth hormone market is expected to experience robust growth post the launch of therapeutic drugs, primarily due to increasing patient base, and long-acting hGH formulations in development. However, the market growth is hindered by high R&D expenditures and expensive drug costs.

The report “Global Human Growth Hormone (Hgh) Market: Industry Analysis & Outlook (2018-2022)” analyzes the development of this market along with the market opportunities. The four major players: Novartis Ag, Pfizer Inc., Eli Lilly and Company, and Novo Nordisk A/S have being profiled along with their key financials and strategies for growth. The report contains a comprehensive analysis of the global market along with the study of the regional markets.


1. Market Overview
1.1 Human Growth Hormone
Table 1: hGH Secretion Control
1.2 Physiological Effects of hGH
Table 2: hGH’s Physiological Effect
1.3 GH Deficiency (GHD)
1.4 Recombinant Human Growth Hormone (rhGH)
1.5 hGH Market by Indications
Table 3: hGH Market Segmentation by Indication
2. Global hGH Market
2.1 Global hGH Market by Value
Table 4: Global hGH Market by Value (2013-2017)
2.2 Global hGH Market Forecast by Value
Table 5: Global hGH Market Forecast by Value (2018-2022)
2.3 Global hGH Market by Volume
Table 6: Global hGH Market by Volume (2013-2017)
2.4 Global hGH Market Forecast by Volume
Table 7: Global hGH Market Forecast by Volume (2018-2022)
2.5 Global hGH Market Share by Indication
Table 8: Global hGH Market Share by Indication (2017)
2.6 Global hGH Market by Indication
2.6.1 Global Pediatric GHD Market Forecast by Value (2017-2022)
Table 9: Global Pediatric GHD Market Forecast by Value (2017-2022)
2.6.2 Global Other GHD Market Forecast by Value (2017-2022)
Table 10: Global Other GHD Market Forecast by Value (2017-2022)
2.7 Global hGH Market by Therapeutics
Table 11: Global hGH Market Share by Daily Agents (2017)
2.8 Global hGH Market Forecast by Therapeutics
Table 12: Global hGH Market Forecast by Therapeutics (2028)
2.9 Global hGH Market by Region
Table 13: Global hGH Market by Region (2017)
3. Regional Markets
3.1 The US
3.1.1 The US hGH Market Forecast by Value
Table 14: The US hGH Market Forecast by Value (2017-2022)
3.1.2 The US hGH Market by Indication
Table 15: The US hGH Market by Indication (2017)
3.1.3 The US Pediatric GHD Patient Population Forecast
Table 16: The US Pediatric GHD Patient Population Forecast (2017-2022)
3.1.4 The US Pediatric GHD Patient Population by Type
Table 17: The US Pediatric GHD Patient Population by Type (2017)
3.2 Europe
3.2.1 Europe hGH Market Forecast by Value
Table 18: Europe hGH Market Forecast by Value (2017-2022)
3.2.2 Europe hGH Market by Indication
Table 19: Europe hGH Market by Indication (2017)
3.2.3 Europe Pediatric GHD Patient Population Forecast
Table 20: Europe Pediatric GHD Patient Population Forecast (2017-2022)
3.2.4 Europe Pediatric GHD Patient Population by Type
Table 21: Europe Pediatric GHD Patient Population by Type (2017)
3.3 Japan
3.3.1 Japan hGH Market Forecast by Value
Table 22: Japan hGH Market Forecast by Value (2017-2022)
3.3.2 Japan hGH Market by Indication
Table 23: Japan hGH Market by Indication (2017)
3.3.3 Japan Pediatric GHD Patient Population Forecast
Table 24: Japan Pediatric GHD Patient Population Forecast (2017-2022)
3.3.4 Japan Pediatric GHD Patient Population by Type
Table 25: Japan Pediatric GHD Patient Population by Type (2017)
4. Global Human Growth Hormone Market Opportunity
4.1 VRS-317
4.1.1 VRS-317 – The US Growth Hormone Deficiency Market
Table 26: The US Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2023)
4.1.2 VRS-317 – European Union (EU) Growth Hormone Deficiency Market
Table 27: EU Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2019-2023)
4.1.3 VRS-317 –Japan Growth Hormone Deficiency Market
Table 28: Japan Pediatric & Adult Growth Hormone Deficiency Market of VRS-317 (2020-2023)
4.2 TransCon hGH
4.2.1 TransCon hGH –The US and ROW Growth Hormone Deficiency Market
Table 29: The US & ROW Pediatric & Adult Growth Hormone Deficiency Market of TransCon hGH (2020-2023)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Long-Acting hGH Formulations in Development
Table 30: Long-Acting hGH Formulations in Development Globally (2017)
5.1.2 Increasing Incidence of Cancer and HIV/AIDS
Table 31: Global New Cancer Patients by Volume (2013-2017)
5.1.3 Rise in GDP Per Capita
Table 32: Global GDP Per Capita (2013-2017)
5.1.4 Increased Spending on Medicines
Table 33: Global Spending on Medicines (2010-2020)
5.1.5 Increasing Global Healthcare Expenditure
Table 34: Global Healthcare Expenditure (2013-3017)
5.2 Trends & Development
5.2.1 Use of TransCon Technology
5.2.2 Development of Auto-Injectors
5.2.3 Rapid Conversion of the Existing Market to Long-Acting Agents
Table 35: Percentage of Pediatric & Adult GHD Patients Treated With Growth Hormone (2017/2020)
5.3 Challenges
5.3.1 High Cost of Treatment
Table 36: Average Annual Cost of hGH Therapy for Children and Adults
5.3.2 High R&D Costs
5.3.3 Side Effects of rhGH
5.3.4 Low Share of Biosimilar
6. Competitive Landscape
6.1 Global hGH Market
6.1.1 Global hGH Market Share Volume by Company
Table 37: Global hGH Market Share Volume by Company (2017)
6.1.2 Pediatric GHD-Long-Acting Hgh Formulations by Company
Table 38: Pediatric GHD Phase III Trial Design with Long-Acting hGH Formulations (2017)
6.1.3 Adult GHD-Long-Acting Hgh Formulations by Company
Table 39: Adult GHD Phase III Trial Design with Long-Acting hGH Formulations (2017)
6.2 The US hGH Market
Table 40: The US hGH Market Value Share by Company (2017)
7. Company Profiles
7.1 Novartis AG
7.1.1 Business Overview
Table 41: Novartis AG’s Net Sales Share by Business Segments (2017)
7.1.2 Financial Overview
Table 42: Novartis AG’s Net Sales and Net Income (2013-2017)
7.1.3 Business Strategies
7.2 Pfizer Inc.
7.2.1 Business Overview
Table 43: Pfizer Inc.’s Revenue Share by Business Segment (2017)
7.2.2 Financial Overview
Table 44: Pfizer Inc.’s Revenue and Net Income (2013-2017)
7.2.3 Business Strategies
Table 45: Project Pipeline in Various Stages of R&D (2017)
7.3 Eli Lilly and Company
7.3.1 Business Overview
Table 46: Eli Lilly and Company’s Revenue Share by Region (2017)
7.3.2 Financial Overview
Table 47: Eli Lilly and Company’s Revenue and Net Income (2013-2017)
7.3.3 Business Strategies
7.4 Novo Nordisk A/S
7.4.1 Business Overview
Table 48: Novo Nordisk A/S Net Sales by Business Segment (2017)
7.4.2 Financial Overview
Table 49: Novo Nordisk A/S’s Net Sales and Net Profit (2013-2017)
7.4.3 Business Strategies
Table 50: Novo Nordisk A/S R&D Expenditure (2015-2017)
Table 51: New Products of Novo Nordisk A/S in Pipeline (2017)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report